Orthopedic Foot and Ankle Center, Ohio

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 2 drugs with upcoming expirations

Activity

Key Events

Details

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

5 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Regulatory

19921 event

FDAFeb 14

Sodium Thiosulfate — SODIUM THIOSULFATE

Application NDA020166 (NDA)

20122 events

FDAFeb 14

Sodium Thiosulfate — SODIUM THIOSULFATE

Application NDA203923 (NDA)

FDAFeb 14

Sodium Nitrite — SODIUM NITRITE

Application NDA203922 (NDA)

20221 event

FDASep 20

Sodium Thiosulfate — PEDMARK

Application NDA212937 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)